Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma

Oncolytic viral (OV) therapy, which uses genetically engineered tumor-targeting viruses, is being increasingly used in cancer clinical trials due to the direct cytolytic effects of this treatment that appear to provoke a robust immune response against the tumor. As OVs enter tumor cells, intrinsic h...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Invest
Asıl Yazarlar: Nakashima, Hiroshi, Kaufmann, Johanna K., Wang, Pin-Yi, Nguyen, Tran, Speranza, Maria-Carmela, Kasai, Kazue, Okemoto, Kazuo, Otsuki, Akihiro, Nakano, Ichiro, Fernandez, Soledad, Goins, William F., Grandi, Paola, Glorioso, Joseph C., Lawler, Sean, Cripe, Timothy P., Chiocca, E. Antonio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639993/
https://ncbi.nlm.nih.gov/pubmed/26524593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI80713
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller